Alpha Tau Medical Ltd (DRTS) Stock Climbs 44.10% This Week; Should you buy?

Alpha Tau Medical Ltd (DRTS) stock has gained 45.60% over the past 12 months, and the average Wall Street analyst rating is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives the DRTS title a score of 15 out of a possible 100.

This ranking is influenced by a short-term technical score of 0. The DRTS ranking also includes a long-term technical score of 0. The fundamental score for DRTS is 45. In addition to the average Wall Street analyst rating, DRTS stock has an average target price of $18.00. This means that analysts expect the stock to climb 28.11% over the next 12 months.

DRTS has an overall score of 15. Find out what this means for you and get the rest of the ranking on DRTS!

What’s happening with DRTS Stock today

Alpha Tau Medical Ltd (DRTS) stock gained 19.27% ​​while the S&P 500 gained 0.37% at 9:36 a.m. Thursday, March 24. DRTS gained $2.27 from the previous closing price of $11.78 on volume of 32,534 shares. Over the past year, the S&P 500 has risen 15.01% while DRTS has gained 45.60%. DRTS has earned $0.16 per share over the past 12 months, giving it a price-earnings ratio of 86.45. Click here for the full Alpha Tau Medical Ltd stock report.

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.

Thank you for signing up! You are ready to receive the Morning Update newsletter

About Clara Barnard

Check Also

Bausch Health Companies – Headwinds, Again (NYSE: BHC)

Prykhodov/iStock via Getty Images Shares of Bausch Health Companies Inc. (NYSE: BHC) continued to slump …